- Report
- January 2024
- 146 Pages
Global
From €3936EUR$4,250USD£3,302GBP
- Report
- December 2023
- 145 Pages
Global
From €4122EUR$4,450USD£3,457GBP
- Report
- December 2023
- 148 Pages
Global
From €4122EUR$4,450USD£3,457GBP
- Report
- October 2023
- 152 Pages
Global
From €4122EUR$4,450USD£3,457GBP
- Report
- October 2023
- 152 Pages
Global
From €4122EUR$4,450USD£3,457GBP
- Report
- October 2023
- 100 Pages
Global
From €3500EUR$4,048USD£3,038GBP
- Report
- May 2024
- 200 Pages
Global
From €3844EUR$4,150USD£3,224GBP
- Report
- May 2024
- 200 Pages
Global
From €3844EUR$4,150USD£3,224GBP
- Report
- May 2024
- 200 Pages
Global
From €3844EUR$4,150USD£3,224GBP
- Report
- May 2024
- 200 Pages
Global
From €3844EUR$4,150USD£3,224GBP
- Report
- May 2024
- 200 Pages
Global
From €3844EUR$4,150USD£3,224GBP
- Report
- March 2024
- 200 Pages
Global
From €3844EUR$4,150USD£3,224GBP
- Report
- January 2024
- 201 Pages
Global
From €4168EUR$4,500USD£3,496GBP
- Report
- November 2023
- 306 Pages
Global
From €3334EUR$3,600USD£2,797GBP
- Report
- January 2024
- 150 Pages
Global
€4626EUR$4,995USD£3,881GBP
- Report
- January 2024
- 306 Pages
Global
€4626EUR$4,995USD£3,881GBP
- Report
- February 2024
- 234 Pages
Global
€4626EUR$4,995USD£3,881GBP
- Report
- December 2023
- 231 Pages
Global
€4626EUR$4,995USD£3,881GBP
- Report
- March 2024
- 207 Pages
Global
From €1850EUR$1,997USD£1,551GBP
- Newsletter
- September 2024
Global
€2774EUR$2,995USD£2,327GBP
T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more